Skip to main content
. 2018 Jun 25;182(2):231–244. doi: 10.1111/bjh.15394

Figure 1.

Figure 1

Waterfall plot of best M‐protein response, among response‐evaluable patients treated at the recommended phase 2 dose (modified intent‐to‐treat population).